Trial intelligence / Profile preview

Oliceridine versus sufentanil for postoperative analgesia after abdominal surgery in AICU patients

ChiCTR2400092109Phase 4Recruiting

Sponsor
Wu Jieping Medical Foundation Committee
Start
Nov 2024
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4 trial of oliceridine and sufentanil in acute pain (2 arms), sponsored by Wu Jieping Medical Foundation Committee. Primary endpoint: Numeric Rating Scale. Started Nov 2024; status: recruiting.

02

Drugs

oliceridinesufentanil
03

Conditions

acute pain

Beyond the preview

Go deeper on ChiCTR2400092109.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400092109.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call